These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34586341)

  • 1. Activated PI3Kδ signals compromise plasma cell survival via limiting autophagy and increasing ER stress.
    Al Qureshah F; Sagadiev S; Thouvenel CD; Liu S; Hua Z; Hou B; Acharya M; James RG; Rawlings DJ
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34586341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated PI3Kδ Specifically Perturbs Mouse Regulatory T Cell Homeostasis and Function Leading to Immune Dysregulation.
    Singh AK; Al Qureshah F; Drow T; Hou B; Rawlings DJ
    J Immunol; 2024 Jul; 213(2):135-147. PubMed ID: 38829130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated PI3Kδ specifically perturbs mouse Treg homeostasis and function leading to immune dysregulation.
    Singh AK; Qureshah FA; Drow T; Hou B; Rawlings DJ
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Roles of Phosphoinositide 3-Kinase δ in the Humoral Immune Response to
    Olayinka-Adefemi F; Onyilagha C; Jayachandran N; Hou S; Jia P; Uzonna J; Marshall AJ
    J Immunol; 2021 Sep; 207(5):1401-1410. PubMed ID: 34380646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated PIK3CD drives innate B cell expansion yet limits B cell-intrinsic immune responses.
    Wray-Dutra MN; Al Qureshah F; Metzler G; Oukka M; James RG; Rawlings DJ
    J Exp Med; 2018 Oct; 215(10):2485-2496. PubMed ID: 30194267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8
    Cannons JL; Villarino AV; Kapnick SM; Preite S; Shih HY; Gomez-Rodriguez J; Kaul Z; Shibata H; Reilley JM; Huang B; Handon R; McBain IT; Gossa S; Wu T; Su HC; McGavern DB; O'Shea JJ; McGuire PJ; Uzel G; Schwartzberg PL
    Cell Rep; 2021 Oct; 37(2):109804. PubMed ID: 34644563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeostatic and pathogenic roles of PI3Kδ in the human immune system.
    Sogkas G; Adriawan IR; Dubrowinskaja N; Atschekzei F; Schmidt RE
    Adv Immunol; 2020; 146():109-137. PubMed ID: 32327151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K pathway defects leading to immunodeficiency and immune dysregulation.
    Nunes-Santos CJ; Uzel G; Rosenzweig SD
    J Allergy Clin Immunol; 2019 May; 143(5):1676-1687. PubMed ID: 31060715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity.
    Preite S; Cannons JL; Radtke AJ; Vujkovic-Cvijin I; Gomez-Rodriguez J; Volpi S; Huang B; Cheng J; Collins N; Reilley J; Handon R; Dobbs K; Huq L; Raman I; Zhu C; Li QZ; Li MO; Pittaluga S; Uzel G; Notarangelo LD; Belkaid Y; Germain RN; Schwartzberg PL
    Nat Immunol; 2018 Sep; 19(9):986-1000. PubMed ID: 30127432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline-activating mutations in
    Avery DT; Kane A; Nguyen T; Lau A; Nguyen A; Lenthall H; Payne K; Shi W; Brigden H; French E; Bier J; Hermes JR; Zahra D; Sewell WA; Butt D; Elliott M; Boztug K; Meyts I; Choo S; Hsu P; Wong M; Berglund LJ; Gray P; O'Sullivan M; Cole T; Holland SM; Ma CS; Burkhart C; Corcoran LM; Phan TG; Brink R; Uzel G; Deenick EK; Tangye SG
    J Exp Med; 2018 Aug; 215(8):2073-2095. PubMed ID: 30018075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.
    Paz K; Flynn R; Du J; Tannheimer S; Johnson AJ; Dong S; Stark AK; Okkenhaug K; Panoskaltsis-Mortari A; Sage PT; Sharpe AH; Luznik L; Ritz J; Soiffer RJ; Cutler CS; Koreth J; Antin JH; Miklos DB; MacDonald KP; Hill GR; Maillard I; Serody JS; Murphy WJ; Munn DH; Feser C; Zaiken M; Vanhaesebroeck B; Turka LA; Byrd JC; Blazar BR
    Am J Transplant; 2019 Jun; 19(6):1820-1830. PubMed ID: 30748099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated PI3Kδ breaches multiple B cell tolerance checkpoints and causes autoantibody production.
    Lau A; Avery DT; Jackson K; Lenthall H; Volpi S; Brigden H; Russell AJ; Bier J; Reed JH; Smart JM; Cole T; Choo S; Gray PE; Berglund LJ; Hsu P; Wong M; O'Sullivan M; Boztug K; Meyts I; Uzel G; Notarangelo LD; Brink R; Goodnow CC; Tangye SG; Deenick EK
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31841125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide 3-Kinase P110δ-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation.
    Oka A; Mishima Y; Liu B; Herzog JW; Steinbach EC; Kobayashi T; Plevy SE; Sartor RB
    Cells; 2019 Sep; 8(10):. PubMed ID: 31546615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.
    Rao VK; Webster S; Dalm VASH; Šedivá A; van Hagen PM; Holland S; Rosenzweig SD; Christ AD; Sloth B; Cabanski M; Joshi AD; de Buck S; Doucet J; Guerini D; Kalis C; Pylvaenaeinen I; Soldermann N; Kashyap A; Uzel G; Lenardo MJ; Patel DD; Lucas CL; Burkhart C
    Blood; 2017 Nov; 130(21):2307-2316. PubMed ID: 28972011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Mechanisms Underlying B Cell Abnormalities in Patients With Gain-of-Function Mutations in the
    Wang W; Min Q; Lai N; Csomos K; Wang Y; Liu L; Meng X; Sun J; Hou J; Ying W; Zhou Q; Sun B; Hui X; Ujhazi B; Gordon S; Buchbinder D; Schuetz C; Butte M; Walter JE; Wang X; Wang JY
    Front Immunol; 2022; 13():890073. PubMed ID: 35799777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.
    Stark AK; Davenport ECM; Patton DT; Scudamore CL; Vanhaesebroeck B; Veldhoen M; Garden OA; Okkenhaug K
    J Immunol; 2020 Jul; 205(1):78-89. PubMed ID: 32414808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated actin dynamics in activated PI3Kδ syndrome.
    Wallace JG; Zambrano-Rodas P; Córdova-Calderón W; Estrada-Turriate S; Mendoza-Quispe D; Limache Ontiveros Y; Geha RS; Chou J; Platt CD
    Clin Immunol; 2020 Jan; 210():108311. PubMed ID: 31760094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner.
    Stark AK; Chandra A; Chakraborty K; Alam R; Carbonaro V; Clark J; Sriskantharajah S; Bradley G; Richter AG; Banham-Hall E; Clatworthy MR; Nejentsev S; Hamblin JN; Hessel EM; Condliffe AM; Okkenhaug K
    Nat Commun; 2018 Aug; 9(1):3174. PubMed ID: 30093657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T and B-cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity.
    Preite S; Gomez-Rodriguez J; Cannons JL; Schwartzberg PL
    Immunol Rev; 2019 Sep; 291(1):154-173. PubMed ID: 31402502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency.
    Elgizouli M; Lowe DM; Speckmann C; Schubert D; Hülsdünker J; Eskandarian Z; Dudek A; Schmitt-Graeff A; Wanders J; Jørgensen SF; Fevang B; Salzer U; Nieters A; Burns S; Grimbacher B
    Clin Exp Immunol; 2016 Feb; 183(2):221-9. PubMed ID: 26437962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.